Behandlung der Psoriasis mit Secukinumab: Praxisrelevante Hinweise

BACKGROUND: Moderate to severe plaque psoriasis can be treated effectively with immunomodulating biologicals such as the interleukin-17A inhibitor secukinumab. In practice, however, questions often arise as to how to proceed in special situations, such as infections, comorbidity, pregnancy, or surge...

Descripción completa

Detalles Bibliográficos
Autores principales: Körber, Andreas, Augustin, Matthias, Behrens, Frank, Gerdes, Sascha, von Kiedrowski, Ralph, Schäkel, Knut, Sticherling, Michael, Wilsmann-Theis, Dagmar, Wohlrab, Johannes, Simon, Jan-Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Übersichten
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378296/
https://www.ncbi.nlm.nih.gov/pubmed/34417630
http://dx.doi.org/10.1007/s00105-021-04871-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378296/
https://www.ncbi.nlm.nih.gov/pubmed/34417630
http://dx.doi.org/10.1007/s00105-021-04871-9

Ejemplares similares